News
Anne Wojcicki, founder and former CEO of 23andMe, will helm the company again after her nonprofit's purchase was approved.
TTAM Research Institute, a non-profit public benefit company also founded by Wojcicki, won the auction with a $305 million bid for the 23andMe assets, which will not come with any company liabilities ...
gaining access to its COPD medication Customers seeking deals gave Amazon’s Prime Day and competing sales a solid start That ...
When popular genetic testing company 23andMe filed for bankruptcy earlier this year and announced it was for sale, privacy ...
The DNA data of millions of people who used 23andMe's services won't be sold to a pharmaceutical company. A bankruptcy judge ...
San Francisco-based 23andMe filed for Chapter 11 bankruptcy protection in the Eastern Missouri federal court district in ...
23andMe's stock, which once traded for more than $300 a share, fell to 79 cents before the start of trade Monday. In January, 23andMe reported a third-quarter net loss of $26.8 million on revenue ...
23andMe is proposing to reopen its bankruptcy auction to entertain a final offer from a nonprofit operated by its co-founder, casting doubt on its deal with Regeneron Pharmaceuticals.
23andMe has filed for bankruptcy as is seeking buyers. ... you can start looking at tens or even hundreds of dollars per individual." 23andMe has access to all of that and more, he said.
Remember 23andMe? The company that gave customers saliva-based DNA testing kits to learn about their ancestry?
NEW YORK (AP) — Anne Wojcicki’s bid to buy 23andMe, the genetic testing company she cofounded nearly 20 years ago, has received the court greenlight. Wall Street is off to a sluggish start ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results